MLD and BML (Japan) announce distribution agreement for PanaSee™ pancreatic cancer screening test kits. Shawn RitchieDecember 17, 2019
MLD and Laval University collaborators publish key Parkinson's disease plasmalogen paper Shawn RitchieOctober 31, 2019
MLD's Plasmalogen Drug PPI-1040 for RCDP receives FDA Orphan Drug Designation (ODD) Shawn RitchieSeptember 5, 2019
MLD granted second Pre-IND meeting with the FDA for PPI-1040 and treatment of RCDP Shawn RitchieJanuary 4, 2019